News

Jenny Van Kirk, MD, currently the chief medical resident for Duke University Hospital, will serve as the associate director of Undergraduate Medical Education (UME) for the Department of Medicine as well as assistant program director for the Internal Medicine Residency Program, effective July 1, 2019.

The Department of Medicine has awarded the 2019 Chair's Research Award to four junior investigators who are making the transition to becoming independent scientists prior to their acquisition of extramural funding.

For women who take hydroxychloroquine (HCQ) to control rheumatic disease, research has shown that it’s best for mother and baby to continue the medicine during pregnancy. But should the dose be maintained, decreased, or increased? Stephen Balevic, MD, assistant professor of pediatrics and medicine (Rheumatology and Immunology), set out to investigate this question using data from the Duke Autoimmunity in Pregnancy registry. 

When a woman with rheumatic disease is pregnant, she may experience many symptoms--some from her underlying disease and some from pregnancy itself. Which of these symptoms signal increased risk for preterm delivery?

Nathaniel Harris, MD, PhD, an intern in the Duke internal medicine residency program, spent his third year of medical school, also at Duke, plumbing the DAP registry for insights into this question.